Intuitive Surgical traded at $468.66 this Thursday March 26th, decreasing $1.32 or 0.28 percent since the previous trading session. Looking back, over the last four weeks, Intuitive Surgical lost 6.92 percent. Over the last 12 months, its price fell by 7.73 percent. Looking ahead, we forecast Intuitive Surgical to be priced at 455.84 by the end of this quarter and at 416.03 in one year, according to Trading Economics global macro models projections and analysts expectations.
Intuitive Surgical, Inc. develops, manufactures and markets the da Vinci surgical system and Ion endoluminal system. The Company's da Vinci products are offered in categories, including da Vinci Surgical Systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems (Firefly) and da Vinci Endoscopes. It also provides a comprehensive suite of services, training, and education programs. It manufactures a set of instruments, which incorporates EndoWrist technology with wristed joints for natural dexterity and tips customized for various surgical procedures. Its Ion endoluminal system is a robotic-assisted, catheter-based platform designed to navigate through very small lung airways to reach peripheral nodules for biopsies. The da Vinci Surgical System enables surgeons to operate while seated at an ergonomic console viewing a three-dimensional, high definition (3DHD) image of the surgical field.